William Plovanic Analyst Performance

Med-Tech Operator and Investment Professional at Canaccord Genuity Group

William Plovanic is a stock analyst at Canaccord Genuity Group focused in the medical sector, covering 42 publicly traded companies. Over the past year, William Plovanic has issued 30 stock ratings, including buy and hold recommendations. While full access to William Plovanic's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights William Plovanic's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 196 Last 11 Years
Buy Recommendations: 83.78% 155 Buy Ratings
Companies Covered: 42 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	83.8%	155 ratings
Hold	16.2%	30 ratings
Sell	0.0%	0 ratings

Out of 185 total stock ratings issued by William Plovanic at Canaccord Genuity Group, the majority (83.8%) have been Buy recommendations, followed by 16.2% Hold.

Best & Worst Calls

Best Call
0000.0%
TMDX
Mar 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
RSLS
Jul 2015
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	73.8% of companies on NASDAQ	31 companies
NYSE	23.8% of companies on NYSE	10 companies
OTCMKTS	2.4% of companies on OTCMKTS	1 company

William Plovanic, an analyst at Canaccord Genuity Group, currently covers 42 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 37 companies	88.1%
	Miscellaneous 4 companies	9.5%
	Computer and Technology 1 company	2.4%

William Plovanic of Canaccord Genuity Group specializes in stock coverage within the Medical sector, with additional focus on and Computer and Technology companies.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 12 companies	28.6%
MED PRODUCTS 8 companies	19.0%
SURGICAL & MEDICAL INSTRUMENTS 6 companies	14.3%
Miscellaneous 4 companies	9.5%
MEDICAL DEVICES 3 companies	7.1%
MEDICAL INFO SYS 2 companies	4.8%
MED/DENTAL - SUPP 2 companies	4.8%
SURGICAL APPLIANCES & SUPPLIES 2 companies	4.8%
HEALTH INFORMATION SERVICES 1 company	2.4%
MED - BIOMED/GENE 1 company	2.4%
ELECTROMEDICAL EQUIPMENT 1 company	2.4%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
HTFL Heartflow	9/2/2025	Initiated Coverage	$31.50	$35.00	Buy
PODD Insulet	8/8/2025	Boost Price Target	$307.10	$353.00	Buy
AORT Artivion	8/8/2025	Boost Price Target	$40.89	$41.00	Buy
TNDM Tandem Diabetes Care	8/7/2025	Set Price Target	$11.18	$24.00	Buy
STIM Neuronetics	8/6/2025	Lower Price Target	$4.21	$7.00	Buy
DXCM DexCom	8/1/2025	Reiterated Rating	$80.05	$106.00	Buy
IRTC iRhythm Technologies	8/1/2025	Boost Price Target	$165.04	$170.00	Buy
EW Edwards Lifesciences	7/25/2025	Boost Price Target	$79.13	$81.00	Hold
GMED Globus Medical	7/22/2025	Lower Price Target	$53.16	$90.00	Buy
ANGO AngioDynamics	7/16/2025	Boost Price Target	$8.65	$17.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
TMDX TransMedics Group	7/15/2025	Boost Price Target	$116.94	$142.00	Buy
AORT Artivion	6/17/2025	Initiated Coverage	$28.68	$35.00	Buy
ZBH Zimmer Biomet	5/12/2025	Lower Price Target	$98.77	$101.00	Hold
IRTC iRhythm Technologies	5/2/2025	Lower Price Target	$131.55	$139.00	Buy
DXCM DexCom	5/2/2025	Boost Price Target	$81.75	$106.00	Buy
TNDM Tandem Diabetes Care	5/1/2025	Boost Price Target	$19.98	$59.00	Buy
EW Edwards Lifesciences	4/25/2025	Boost Price Target	$75.15	$75.00	Hold
CVRX CVRx	4/8/2025	Lower Price Target	$11.54	$18.00	Buy
ATRC AtriCure	3/28/2025	Lower Price Target	$34.37	$52.00	Buy
TLSI TriSalus Life Sciences	3/28/2025	Reiterated Rating	$5.44	$11.00	Buy
TMDX TransMedics Group	3/11/2025	Reiterated Rating	$67.54	$104.00	Buy
STIM Neuronetics	3/5/2025	Boost Price Target	$5.42	$8.00	Buy
CBLL CeriBell	2/26/2025	Reiterated Rating	$25.90	$33.00	Buy
TNDM Tandem Diabetes Care	2/26/2025	Reiterated Rating	$33.83	$63.00	Buy
DXCM DexCom	2/14/2025	Boost Price Target	$84.09	$103.00	Buy
EW Edwards Lifesciences	2/13/2025	Boost Price Target	$75.83	$71.00	Hold
ATRC AtriCure	2/13/2025	Boost Price Target	$42.36	$66.00	Buy
NVRO Nevro	2/7/2025	Boost Price Target	$5.72	$5.85	Hold
CVRX CVRx	2/5/2025	Boost Price Target	$16.25	$23.00	Buy
GMED Globus Medical	1/10/2025	Boost Price Target	$88.42	$101.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.